Department of Obstetrics and Fetal Medicine, Leiden University Medical Centre, Leiden, The Netherlands.
Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.
BJOG. 2022 Oct;129(11):1805-1816. doi: 10.1111/1471-0528.17164. Epub 2022 Apr 15.
Birthweight (BW) is an important prognostic factor in newborns with congenital heart defects (CHD).
To give an overview of the literature on BW z-score in children with isolated CHD.
A systematic search was performed on isolated CHD and BW in PubMed, Embase, Web of Science, COCHRANE Library and Emcare.
Neonates with isolated CHD were included if a BW percentile, BW z-score or % small-or-gestational age (SGA) was reported.
BW z-score and percentage SGA were pooled with random-effect meta-analysis. Quality and risk of bias were assessed using the modified Newcastle Ottawa Scale.
Twenty-three articles (27 893 cases) were included. BW z-scores were retrieved from 11 articles, resulting in a pooled z-score of -0.20 (95% CI -0.50 to 0.11). The overall pooled prevalence of SGA <10th percentile was 16.0% (95% CI 11.4-20.5; 14 studies). Subgroup analysis of major CHD showed similar results (BW z-score -0.23 and percentage SGA 16.2%).
Overall BW in isolated CHD is within range of normality but impaired, with a 1.6-fold higher risk of SGA, irrespective of the type of CHD (major CHD vs all CHD combined). Our findings underline the association between CHD and BW. The use of BW z-scores provides insight into growth of all fetuses with CHD.
Infants with a congenital heart defect (CHD) have a lower birthweight z-score and a higher incidence of small-for-gestational age (<10th percentile). This was encountered both in the major CHD-group as well as in all-CHD combined group analysis. Future research on the association between birthweight and CHD should include all types of CHDs (including mild cardiac defects) and placental-related disease, such as pre-eclampsia. We advocate the use of international standardised fetal growth and birthweight charts in CHD research.
出生体重(BW)是新生儿先天性心脏病(CHD)的一个重要预后因素。
综述孤立性 CHD 患儿 BW z 评分的文献。
在 PubMed、Embase、Web of Science、Cochrane 图书馆和 Emcare 中对孤立性 CHD 和 BW 进行系统检索。
纳入 BW 百分位数、BW z 评分或%小胎龄(SGA)有报道的新生儿。
采用随机效应荟萃分析对 BW z 评分和 SGA%进行汇总。使用改良的 Newcastle-Ottawa 量表评估质量和偏倚风险。
纳入 23 篇文章(27893 例)。11 篇文章中检索到 BW z 评分,汇总的 z 评分为-0.20(95% CI -0.50 至 0.11)。SGA <10 百分位的总体汇总患病率为 16.0%(95% CI 11.4-20.5;14 项研究)。主要 CHD 的亚组分析显示出类似的结果(BW z 评分-0.23 和 SGA%16.2%)。
孤立性 CHD 的总体 BW 在正常范围内,但受损,SGA 的风险增加 1.6 倍,与 CHD 类型无关(主要 CHD 与所有 CHD 合并)。我们的研究结果强调了 CHD 与 BW 之间的关联。BW z 评分的使用可以深入了解所有患有 CHD 的胎儿的生长情况。
患有先天性心脏病(CHD)的婴儿出生体重 z 评分较低,小胎龄(<10 百分位)的发生率较高。在主要 CHD 组和所有 CHD 合并组分析中均发现了这一情况。未来关于 BW 与 CHD 之间关联的研究应包括所有类型的 CHD(包括轻度心脏缺陷)和胎盘相关疾病,如子痫前期。我们主张在 CHD 研究中使用国际标准化胎儿生长和 BW 图表。